Quick Answer
Phathom Pharmaceuticals, Inc. reported Total Revenue of $175.11 million for fiscal year 2025.
Phathom Pharmaceuticals, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $175.11M | +216.9% |
| 2024 | $55.25M | +8001.5% |
| 2023 | $682.0K | — |
| 2022 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $49.50M | +202.7% | +25.3% |
| June 30, 2025 | $39.50M | +439.4% | +38.5% |
| March 31, 2025 | $28.52M | +1391.6% | +74.4% |
| September 30, 2024 | $16.35M | — | +123.3% |
| June 30, 2024 | $7.32M | — | +283.1% |
| March 31, 2024 | $1.91M | — | — |
| September 30, 2023 | $0.00 | — | — |
| June 30, 2023 | $0.00 | — | — |
- Phathom Pharmaceuticals, Inc. showed an increase of +216.9% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Phathom Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: